38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Telbivudine 20 mg/mL oral solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cocaine 100 mg/g nasal paste	Count of base of active ingredient	False	un	Inferred relationship	Some
Cocaine 100 mg/g nasal paste	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ibuprofen 40 mg/mL oral suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Ibuprofen 40 mg/mL oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely baclofen 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely baclofen 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Estradiol 100 mg prolonged-release subcutaneous implant	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Estradiol 100 mg prolonged-release subcutaneous implant	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Sevelamer carbonate 2.4 g powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Sevelamer carbonate 2.4 g powder for oral suspension sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely plerixafor 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely plerixafor 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely macrogol 3350 17 gram/1 sachet powder for conventional release oral solution (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely macrogol 3350 17 gram/1 sachet powder for conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Diazepam 2 mg/mL rectal solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Diazepam 2 mg/mL rectal solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely diazepam 4 milligram/1 milliliter conventional release rectal solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely diazepam 4 milligram/1 milliliter conventional release rectal solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Risperidone 12.5 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Risperidone 12.5 mg powder for suspension for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Mesalazine 66.7 mg/mL rectal suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Mesalazine 66.7 mg/mL rectal suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Colesevelam hydrochloride 1.875 g powder for oral suspension sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Colesevelam hydrochloride 1.875 g powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Risperidone 50 mg powder for suspension for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Risperidone 50 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Levonorgestrel 75 mg prolonged-release subcutaneous implant	Count of base of active ingredient	False	un	Inferred relationship	Some
Levonorgestrel 75 mg prolonged-release subcutaneous implant	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Fentanyl 12 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Fentanyl 12 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely colesevelam hydrochloride 3.75 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely colesevelam hydrochloride 3.75 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Sotalol hydrochloride 15 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sotalol hydrochloride 15 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Ixabepilone 15 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ixabepilone 15 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pegloticase 8 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pegloticase 8 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sevelamer carbonate 800 mg powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Sevelamer carbonate 800 mg powder for oral suspension sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Colestyramine 4 g powder for oral suspension sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Colestyramine 4 g powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cabazitaxel 40 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Cabazitaxel 40 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ecallantide 10 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Ecallantide 10 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely sodium para-aminohippurate 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely sodium para-aminohippurate 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some

Start Previous Page 185 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module